Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02128477Completed

Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients

Role: lead

NCT01486589Completed

Cardiac Autonomic Function For Risk Stratification in the Emergency Room

Role: lead

NCT01422044Completed

Risk Prediction in Aortic Stenosis

Role: lead

NCT01422057Unknown

Risk Prediction in Type II Diabetics With Ischemic Heart Disease

Role: lead

All 4 trials loaded